EUVIMEDOpdag EUVIMED
Crossref

Altered expression of S100 fused‐type proteins in an atopic dermatitis skin model

Teruhiko Makino iD, Megumi Mizawa, Keita Takemoto iD, Seiji Yamamoto, Tadamichi Shimizu

Experimental Dermatology · 2023

DOI: 10.1111/exd.14797 ↗

At a glance

Journal article in Experimental Dermatology, 2023. Written by Teruhiko Makino and 4 co-authors. Institution: Department of Dermatology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Toyama, Japan. Major MEDLINE topics: Dermatitis, Atopic. Cited 8 times so far (Crossref); 24 references. Funded by: Japan Society for the Promotion of Science.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Atopic dermatitis (AD) is a chronic inflammatory skin disorder with elevated interleukin (IL)‐4 and IL‐13 signatures and extensive barrier dysfunction, which is correlated with the downregulation of filaggrin (FLG). FLG is a member of the S100 fused‐type protein family and this family also includes cornulin (CRNN), filaggrin‐2 (FLG2), hornerin (HRNR) repetin (RPTN), trichohyalin (TCHH) and trichohyalin‐like 1 (TCHHL1). The present study aimed to examine the effects of IL‐4 and IL‐13 and the downregulation of FLG on the expression of S100 fused‐type proteins using a three‐dimensional (3D) AD skin model by immunohistochemical study and quantitative polymerase chain reaction. In the 3D AD skin model, which was generated by a stimulation of recombinant IL‐4 and IL‐13, the expression of FLG, FLG2, HRNR and TCHH was decreased, while that of RPTN was increased in comparison to the 3D control skin. In the FLG knockdown (KD) 3D skin model, which was generated using FLG siRNA, the expression of HRNR was increased. The expression of the other proteins did not differ to a statistically significant extent. The expression of fused‐S100 type protein family members may differ in AD skin. This suggests that these proteins play different roles in the pathogenesis of AD.

Subjects

MeSH terms (MEDLINE)

Dermatitis, AtopicHumansFilaggrin ProteinsInterleukin-4Interleukin-13SkinS100 ProteinsIntermediate Filament Proteins

Author keywords

S100 fused-type proteinsatopic dermatitisfilaggrinthree-dimensional skin equivalenttype 2 cytokines

Substances

Filaggrin ProteinsInterleukin-4Interleukin-13S100 ProteinsIntermediate Filament Proteins

Authors and institutions

  • Department of Dermatology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Toyama, Japan.
  • Department of Pathology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Toyama, Japan.

ORCID profiles: Teruhiko Makino, Keita Takemoto

Funding

  • Japan Society for the Promotion of Science

Cite

APA

Makino, T., Mizawa, M., Takemoto, K., Yamamoto, S., & Shimizu, T. (2023). Altered expression of S100 fused‐type proteins in an atopic dermatitis skin model. Experimental Dermatology. https://doi.org/10.1111/exd.14797

Vancouver

Makino T, Mizawa M, Takemoto K, Yamamoto S, Shimizu T. Altered expression of S100 fused‐type proteins in an atopic dermatitis skin model. Experimental Dermatology. 2023. doi:10.1111/exd.14797

BibTeX
@article{Makino2023,
  author = {Makino, Teruhiko and Mizawa, Megumi and Takemoto, Keita and Yamamoto, Seiji and Shimizu, Tadamichi},
  title = {Altered expression of S100 fused‐type proteins in an atopic dermatitis skin model},
  journal = {Experimental Dermatology},
  year = {2023},
  doi = {10.1111/exd.14797}
}
Start for free →